Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

1.3K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
Neural Regulation01:37

Neural Regulation

43.6K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Schmerz (Berlin, Germany)·2026
Same author

Effect of subcutaneous foslevodopa/foscarbidopa therapy on non-motor symptoms in advanced PD patients.

Journal of neurology·2026
Same author

[German guideline on spinal cord stimulation for chronic neuropathic pain].

Schmerz (Berlin, Germany)·2026
Same author

The deep brain stimulation response network in Parkinson's disease operates in the high beta band.

Brain : a journal of neurology·2026
Same author

Quantity and quality of care and staff knowledge regarding people with Parkinson's disease in long-term nursing care: "real-life" results from the German Care4PD study.

Frontiers in aging neuroscience·2026
Same author

Electrophysiological signatures predict the therapeutic window of deep brain stimulation electrode contacts.

NPJ digital medicine·2025

Related Experiment Video

Updated: Feb 24, 2026

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

16.4K

[Driving ability in Parkinson's disease].

Carsten Buhmann1, Jan Vesper2, Henriette Oelsner3

  • 1Universitätsklinikum Hamburg-Eppendorf, Ambulanzzentrum und Neurologische Klinik.

Fortschritte Der Neurologie-Psychiatrie
|August 16, 2017
PubMed
Summary
This summary is machine-generated.

Many Parkinson's disease (PD) patients drive, but symptoms and treatments can impair driving ability. Physicians need guidance on assessing fitness to drive for PD patients, including those with deep brain stimulation (DBS).

More Related Videos

Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease
10:32

Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease

Published on: June 17, 2013

56.4K
Behavioral Assessments of Spontaneous Locomotion in a Murine MPTP-induced Parkinson's Disease Model
05:38

Behavioral Assessments of Spontaneous Locomotion in a Murine MPTP-induced Parkinson's Disease Model

Published on: January 7, 2019

19.0K

Related Experiment Videos

Last Updated: Feb 24, 2026

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

16.4K
Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease
10:32

Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease

Published on: June 17, 2013

56.4K
Behavioral Assessments of Spontaneous Locomotion in a Murine MPTP-induced Parkinson's Disease Model
05:38

Behavioral Assessments of Spontaneous Locomotion in a Murine MPTP-induced Parkinson's Disease Model

Published on: January 7, 2019

19.0K

Area of Science:

  • Neurology
  • Neuroscience
  • Transportation Safety

Background:

  • Approximately 60% of Parkinson's disease (PD) patients and 50% of those with deep brain stimulation (DBS) actively drive.
  • Motor and non-motor symptoms of PD, along with medications and DBS, can significantly impact driving ability.
  • Assessing driving fitness in PD patients is challenging due to a lack of standardized tests and poor correlation between motor impairment and driving skills.

Purpose of the Study:

  • To review motor and non-motor symptoms affecting driving capability in Parkinson's disease.
  • To outline criteria for determining temporary or permanent driving unfitness in PD patients.
  • To guide the evaluation and advisory process for PD patients with DBS regarding driving fitness.

Main Methods:

  • Literature review of studies on Parkinson's disease, driving ability, and deep brain stimulation.
  • Analysis of motor and non-motor symptoms relevant to driving.
  • Examination of neuropsychological assessments for driving capability evaluation.
  • Review of guidelines for assessing driving fitness in PD patients, including those with DBS.

Main Results:

  • Parkinson's disease symptoms (e.g., motor deficits, cognitive impairment, visual disturbances) can compromise driving.
  • Medications and deep brain stimulation (DBS) can alter driving performance.
  • Standardized assessment tools are lacking, making clinical judgment crucial but difficult.
  • Specific neuropsychological tests can aid in evaluating driving-relevant functions.

Conclusions:

  • Driving ability in Parkinson's disease is complex and influenced by multifactorial elements.
  • Clear criteria and appropriate neuropsychological assessments are needed to advise PD patients on driving fitness.
  • Special considerations are required for evaluating PD patients with deep brain stimulation (DBS).